Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition

Menopause

Volumn 15, Issue 1, 2008, Pages 105-111

  Mitchell, Ellen S ^a   Farin, Frederico M ^a   Stapleton, Patricia L ^a   Tsai, Jesse M ^a   Tao, Eunice Yun ^a   Smith Dijulio, Kathleen ^a   Woods, Nancy F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Final menstrual period; Genetic variability; Menarche; Menopausal transition

Indexed keywords

ESTROGEN;

3' UNTRANSLATED REGION; ADULT; AGE DISTRIBUTION; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CYTOCHROME P450 17 GENE; CYTOCHROME P450 19 GENE; CYTOCHROME P450 1A1 GENE; CYTOCHROME P450 1B1 GENE; DNA POLYMORPHISM; ESTROGEN RECEPTOR GENE; ESTROGEN SYNTHESIS; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MENARCHE; MENSTRUAL CYCLE; NUCLEOTIDE REPEAT; WILD TYPE;

ADULT; AGE FACTORS; ALLELES; AROMATASE; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LONGITUDINAL STUDIES; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; STATISTICS, NONPARAMETRIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 38049024046     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31804d2406     Document Type: Article

References (25)

1. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878.
2. World Health Organization. Report of a WHO Scientific Group. Research on the Menopause in the 1990's. WHO Technical Report Series 866. Geneva, Switzerland: World Health Organization, 1996.
3. Stavrou I, Zois C, Ioannidis JPA, Tsatsoulis A. Association of polymorphisms of the oestrogen receptor α gene with the age of menarche. Hum Reprod 2002;17:1101-1105.
4. Gorai I, Tanaka K, Inada M, et al. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-α gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. J Clin Endocrinol Metab 2003;88:799-803.
5. Lai J, Vesprini WC, Hernstrom H, Narod SA. CYP gene polymorphisms and early menarche. Mol Genet Metab 2001;74:449-457.
6. Murabito JM, Yang Q, Fox CS, Cupples LA. Genome-wide linkage analysis to age at natural menopause in a community based sample: the Framingham Heart Study. Fertil Steril 2005;84:1674-1679.
7. Treloar SA, Sadrzadeh S, Do KA, Martin NG, Lambalk CB. Birth weight and age at menopause in Australian female twin pairs: exploration of the fetal origin hypothesis. Hum Reprod 2000;15:55-59.
8. Do KA, Treloar SA, Pandeya N, et al. Predictive factors of age at menopause in a large Australian twin study. Am J Hum Biol 1998;70:1073-1091.
9. Snieder H, MacGregor AJ, Spencer TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
10. Torgerson DJ, Thomas RE, Reid DM. Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol 1997;74:63-66.
11. Hefler LA, Grimm C, Heinze G, et al. Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod 2005;20:1422-1427.
12. Weel AEAM, Uitterlinden SG, Westendorp ICD, et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 1999;84:3146-3150.
13. Somner J, McLellan S, Cheung J, et al. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyasse) and P450 c19 (aromatase) genes: association with serum sex steroid concentration and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2004;89:344-351.
14. Tworoger SS, Chubak J, Aiello EJ, et al. Association of CYP17, CYP-19, CYP1B1, and COMT polymorphisms and serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:94-101.
15. Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in premenopausal women. Int J Cancer 2002;102:172-178.
16. Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. J Cancer Res 1999;59:1015-1020.
17. Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. J Cancer Res 1998;58:585-587.
18. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334-349.
19. Chiazze L Jr, Brayer FT, Macisco JJ Jr, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968;203:377-380.
20. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967;12:77-126.
21. Garrow JS, Webster J. Quetelet's index (W/H2) as a measure of fatness. Int J Obes 1985;9:147-153.
22. Online encyclopedia for genetic epidemiologic studies. Available at: http//www.genes.org.uk/software/hardy-weinberg.shtml. Accessed July 19, 2006.
23. Haiman CA, Hankinson SE, Spiegelman D, et al. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 2000;87:204-210.
24. Baxter SW, Choong DYH, Eccles DM, Campbell IG. Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 2001;22:347-349.
25. Woods NF, Mitchell ES, Tao EY, Viernes H-MA, Farin FM. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2006;13:902-910.